|
2025
|
Invention
|
Lipidoid compounds and related compositions and uses. Compositions comprising lipidoid compounds,... |
|
|
Invention
|
Methods and compositions for enhancing in vivo persistence and potency of cell therapy. The prese... |
|
2024
|
Invention
|
Compositions targeting klkb1 and methods of use thereof. KLKB1KLKB1 gene. Also provided are cell ... |
|
|
Invention
|
Compositions and methods for integration of viral vectors. The present disclosure relates to comp... |
|
|
Invention
|
Lipidoid compounds and related compositions and uses. The present disclosure provides lipidoid co... |
|
|
Invention
|
Modified stem cell memory t cells, methods of making and methods of using same.
The disclosure p... |
|
|
Invention
|
Compositions targeting hbg1 and hbg2 and methods of use thereof. Disclosed are methods and compos... |
|
|
Invention
|
Transposases and uses thereof. This disclosure generally relates to transposase domains, in parti... |
|
|
Invention
|
Chimeric transposases and uses thereof. This disclosure generally relates to chimeric transposase... |
|
|
Invention
|
Transposases and uses thereof. This disclosure generally relates to fusion proteins comprising tr... |
|
|
Invention
|
Super minimal inverted terminal repeat (itr) sequences and uses thereof. This disclosure generall... |
|
|
Invention
|
Transposase polynucleotides and uses thereof. Provided are polynucleotides for expressing transpo... |
|
|
Invention
|
Compositions and methods for genome editing. Disclosed are methods and compositions for functiona... |
|
|
Invention
|
Aav piggybac transposon polynucleotide compositions and methods of use therefor. The present disc... |
|
2023
|
Invention
|
Chimeric cd8-alpha co-receptor compositions and methods of use. Disclosed are chimeric CD8α co-re... |
|
|
Invention
|
Sulfur-containing compounds and compositions thereof for delivery of nucleic acids. in vivoex viv... |
|
|
Invention
|
Compositions and methods for selective elimination and replacement of hematopoietic stem cells.
... |
|
|
Invention
|
Inducible caspases and methods for use. The disclosure provides inducible caspase polypeptides, c... |
|
|
Invention
|
Genetically modified cells and methods of use thereof.
Disclosed are methods and compositions fo... |
|
|
Invention
|
Genetically modified cells and methods of use thereof. Disclosed are methods and compositions for... |
|
|
Invention
|
Compositions and methods for delivery of nucleic acids.
Compositions comprising terpene-containi... |
|
|
Invention
|
Compositions and methods for delivery of nucleic acids. Compositions comprising terpene-containin... |
|
2022
|
Invention
|
Hyperactive piggybac transposases.
The present invention provides PiggyBac transposase proteins,... |
|
|
Invention
|
Transposon compositions and methods of use thereof.
This disclosure provides compositions and me... |
|
|
Invention
|
Transposase and uses thereof.
This disclosure generally relates to transposase domains, in parti... |
|
|
Invention
|
Transposon compositions and methods of use thereof. This disclosure provides compositions and met... |
|
|
Invention
|
Compositions and methods for directing proteins to specific loci in the genome.
Disclosed are co... |
|
|
Invention
|
Compositions and methods for the treatment of hemophilia.
The present disclosure is directed to ... |
|
|
Invention
|
Compositions and methods for the treatment of hemophilia. The present disclosure is directed to c... |
|
|
Invention
|
Compositions and methods for delivery of nucleic acids.
The present disclosure provides composit... |
|
|
Invention
|
Genetically modified induced pluripotent stem cells and methods of use thereof.
Disclosed are me... |
|
|
Invention
|
Compositions and methods for delivery of nucleic acids. The present disclosure provides compositi... |
|
|
Invention
|
Genetically modified induced pluripotent stem cells and methods of use thereof. Disclosed are met... |
|
2021
|
G/S
|
Kits comprised of diagnostic chemical preparations for use in the fields of medical scientific re... |
|
|
G/S
|
Kits comprised of genetically engineered cell lines,
reagents, enzyme substrates and chemical pr... |
|
|
G/S
|
Kits comprised of genetically engineered cell lines, reagents, enzyme substrates and chemical pre... |
|
|
G/S
|
Biological preparations for use in medical and clinical cell therapy; gene therapy products, name... |
|
|
Invention
|
Compositions and methods for use in the treatment of cancer.
Disclosed are chimeric antigen rece... |
|
|
Invention
|
Compositions and methods for use in the treatment of cancer. Disclosed are chimeric antigen recep... |
|
|
Invention
|
Chimeric stimulatory receptors and methods of use in t cell activation and differentiation.
Disc... |
|
|
Invention
|
Chimeric stimulatory receptors and methods of use in t cell activation and differentiation. Discl... |
|
|
Invention
|
Compositions and methods for the treatment of metabolic liver disorders.
The present disclosure ... |
|
|
Invention
|
Compositions and methods for the treatment of metabolic liver disorders. The present disclosure i... |
|
2020
|
Invention
|
Anti-muc1 compositions and methods of use.
Disclosed are antibodies against MUC1, MUC1-CAR compo... |
|
2019
|
Invention
|
Nanotransposon compositions and methods of use.
Disclosed are compositions comprising a first nu... |
|
|
Invention
|
Allogeneic cell compositions and methods of use.
Disclosed are chimeric stimulatory receptors (C... |
|
2018
|
G/S
|
Reagents and kits comprising reagents for research use in connection with cell manipulation, cell... |
|
|
G/S
|
DNA modification kits comprised of genetically engineered cell lines, reagents, enzyme substrates... |
|
|
G/S
|
Reagents and kits comprising reagents for research use in
connection with cell manipulation, cel... |
|
|
G/S
|
Reagents, nucleic acids, and nucleotides for scientific and research use in the fields of clinica... |
